Notice Number: NOT-AI-05-034

Key Dates
Release Date: April 12, 2005
Application Receipt Date(s): November 14, 2005
Peer Review Date(s): March, 2006
Council Review Date(s) : May, 2006
Earliest Anticipated Start Date: June 2006
Expiration Date: November 15, 2005

The National Institute of Allergy and Infectious Diseases (NIAID) is amending PAR-03-095, Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Program as follows.

The new contact for peer review issues is now:

Dr. Eugene Baizman
Division of Extramural Affairs
National Institute of Allergy and Infectious Diseases
Room Number 3125, MSC-7616
6700-B Rockledge Drive
Bethesda, MD 20892
Telephone: (301) 496-2550
FAX: (301) 402-2638
Email: [email protected]

In addition the two extra copies of the application packet and all five sets of appendix material are to be sent to Dr. Baizman.

Inquiries

Direct questions about scientific/research issues to:

Dr. Michael Pensiero
Division of AIDS
National Institute of Allergy and Infectious Diseases
Room Number 4109, MSC-7628
6700-B Rockledge Drive
Bethesda, MD 20892-7628
Telephone: (301) 435-3749
FAX: (301) 402-3684
Email: [email protected]

Direct questions about financial or grants management matters to:

Victoria P. Connors
Division of Extramural Affairs
National Institute of Allergy and Infectious Diseases
Room Number 2121, MSC-7614
6700-B Rockledge Drive
Bethesda, MD 20892-7614
Telephone: (301) 402-6579
FAX: (301) 480-3780
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®